Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GeneDx Holdings Corp WGS

Financial Services Healthcare
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing... see more

Recent & Breaking News (NDAQ:WGS)

Sema4 Holdings Corp. Class Action: Levi & Korsinsky Reminds Sema4 Holdings, Corp. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2022 - SMFR

Newsfile November 1, 2022

MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Sema4 Holdings Corp. with Losses of $100,000 to Contact the Firm

Newsfile November 1, 2022

SMFR ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 7, 2022 in the Class Action Filed on Behalf of Sema4 Holdings, Corp. Shareholders

PR Newswire November 1, 2022

SMFR LAWSUIT ALERT: Levi & Korsinsky Notifies Sema4 Holdings, Corp. Investors of a Class Action Lawsuit and Upcoming Deadline

Newsfile October 31, 2022

SMFR 1-WEEK DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Sema4 Holdings (SMFR) Investors with Significant Losses to Contact Firm's Attorneys Before Nov. 7th Deadline in Securities Class Action

Newsfile October 31, 2022

Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies

GlobeNewswire October 31, 2022

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Sema4 Holdings Corp. with Losses of $100,000 to Contact the Firm

Newsfile October 31, 2022

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Sema4 Holdings Corp. Investors of a Lead Plaintiff Deadline of November 7, 2022

PR Newswire October 31, 2022

Sema4 Holdings Corp. Class Action: Levi & Korsinsky Reminds Sema4 Holdings, Corp. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2022 - SMFR

Newsfile October 30, 2022

Sema4 Deadline Alert

Newsfile October 30, 2022

SEMA4 HOLDINGS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sema4 Holdings Corp. - SMFR

PR Newswire October 28, 2022

Sema4 Holdings Corp. Class Action: Levi & Korsinsky Reminds Sema4 Holdings, Corp. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2022 - SMFR

Newsfile October 28, 2022

SMFR SHAREHOLDER ALERT: Jakubowitz Law Reminds Sema4 Holdings Corp. Shareholders of a Lead Plaintiff Deadline of November 7, 2022

PR Newswire October 28, 2022

Sema4 Holdings Corp. Class Action: Levi & Korsinsky Reminds Sema4 Holdings, Corp. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2022 - SMFR

Newsfile October 27, 2022

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sema4 Holdings (SMFR) Investors with Significant Losses to Contact Firm's Attorneys Before Nov. 7th Deadline in Securities Class Action

Newsfile October 27, 2022

Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns

GlobeNewswire October 27, 2022

SMFR LAWSUIT ALERT: Levi & Korsinsky Notifies Sema4 Holdings, Corp. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire October 27, 2022

SEMA4 HOLDINGS CORP. (SMFR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Sema4 Corp. (SMFR)

Newsfile October 27, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sema4 Holdings Corp. - SMFR; SMFRW

PR Newswire October 26, 2022

SMFR LAWSUIT ALERT: Levi & Korsinsky Notifies Sema4 Holdings, Corp. Investors of a Class Action Lawsuit and Upcoming Deadline

Newsfile October 26, 2022